BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Business

  Jiangbo Pharmaceuticals, Inc. (Formerly known as Genesis Pharmaceuticals Enterprises, Inc.) Announces Conference Call to Discuss Results for First Quarter Fiscal 2011

  November 11, 2010

   · 

  2 min read
• Biotech Beach

  Aires Pharmaceuticals Completes $20M Equity Financing and Signs an Option Agreement with a Major Pharmaceutical Company

  November 11, 2010

   · 

  2 min read
• Genetown

  Royal Phillips Electronics Announces Its Portfolio of Lifesaving Solutions Supports New American Heart Association 2010 CPR and ECC Guidelines

  November 11, 2010

   · 

  4 min read
• Policy

  Echo Therapeutics Announces Filing of 510(k) Submission Seeking Market Clearance from FDA for its Prelude SkinPrep System and 4% Lidocaine Cream

  November 11, 2010

   · 

  4 min read
• Drug Development

  NephRx Corporation Initiates Phase I Trial of its Lead Drug Being Developed for Prevention of Delayed Graft Function in Kidney Transplant Patients

  November 11, 2010

   · 

  3 min read
• Pharm Country

  Omthera Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 7th Annual Healthcare Conference

  November 11, 2010

   · 

  1 min read
• Biotech Bay

  NeurogesX, Inc. to Present at Lazard Capital Markets Healthcare Conference

  November 11, 2010

   · 

  3 min read
• BioMidwest

  Stereotaxis, Inc. Announces Public Offering of Common Stock

  November 11, 2010

   · 

  4 min read
• Lone Star Bio

  Access Pharmaceuticals Presents CobOral(TM) Insulin Research at 10th Annual Diabetes Technology Meeting on November 11-13, 2010

  November 11, 2010

   · 

  3 min read
• Policy

  Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI(R) Label to Include Inhibition of Structural Damage in Treatment of Psoriatic Arthritis

  November 11, 2010

   · 

  8 min read